Angelini Pharma

Showing 2 posts of 2 posts found.


Angelini Pharma and JCR Pharmaceuticals partner to develop new epilepsy therapies

May 12, 2023
Sales and Marketing Angelini Pharma, JCR Pharmaceuticals, Neurology, epilepsy

Angelini Pharma and JCR Pharmaceuticals have announced that they have entered into an exclusive global development and commercialisation agreement for …


Angelini Pharma to acquire Arvelle Therapeutics in $960 million deal

January 6, 2021
Research and Development Angelini Pharma, central nervous system

Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …

Latest content